Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUPRODEX
NCT02096068Phase 4Completed
- Start
- Jul 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in delirium and postoperative cognitive dysfunction (POCD) (3 arms). Primary endpoint: Incidence of postoperative delirium at 5 days. Started Jul 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
deliriumpostoperative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02096068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096068.